Scientific Terms
TwinStrand Biosciences Sues Guardant Health for Alleged Patent Infringement
The company argued in its complaint that Guardant's liquid biopsy assays have willfully infringed its patented duplex sequencing technology.
Burning Rock Biotech, Impact Therapeutics Partner on CDx for PARP Inhibitor Senaparib
The NGS firm will work with Impact to develop companion diagnostics to select patients eligible for Impact's synthetic lethality drugs, beginning with senaparib.
Veracyte Aims to Broaden Reach of Decipher Prostate Assay as Studies Continue to Expand Utility
Premium
The company reported significant momentum in test volumes for the second quarter of this year as new publications shore up utility evidence and open new applications.
Intelligent Fingerprinting Adding SARS-CoV-2 Saliva Test to Portfolio of Drug-Testing Assays
Premium
The company plans to launch its COVID-19 test in the early fall with CE marking and submit to the US Food and Drug Administration for Emergency Use Authorization.
Siemens Healthineers Q3 Diagnostics Revenues Almost Double on Rapid Antigen Test Demand
The firm reported total revenues rose 51 percent year over year to €5.00 billion and said full-year 2021 revenues are expected to be up 17 to 19 percent.